Company intelligence / Profile preview

Shanghai Harvest Pharmaceutical

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai Harvest Pharmaceutical is a leading manufacturer of small volume parenteral pharmaceuticals (mainly generics) with an emphasis on emergency and life-saving drugs. Its approved drugs include digoxin for cardiac arrhythmias and bromhexine hydrochloride for respiratory infections, among others. The company operates at the commercial stage and is recognized for manufacturing quality and efficiency, with WHO prequalified manufacturing capabilities.

Therapeutic areas: Infectious DiseasesOtherCardiovascular
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

sodium dihydrogen phosphate and disodium hydrogen phosphate granules

Unknown

Partnerships

Shanghai Pharmaceutical GroupHong Kong Hoting Ltd.Elan Pharma of Ireland

Beyond the preview

Go deeper on Shanghai Harvest Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Harvest Pharmaceutical.

Explore the full profile